GlassScriptPhysician profile
Danielle Louise Cobb
NPI 1982024592
$18,366.64
in general payments reported to CMS, 2019-2025
25 companies · $4,807 in 2025
The $4,807 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.32 · 2022: $4,381 · 2023: $2,198 · 2024: $6,948 · 2025: $4,807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,574 · Travel and Lodging: $5,379 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,573.83 |
| Travel and Lodging | $5,379.30 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,205.56 | 2022-2024 | Da Vinci Surgical System |
| Davol INC. | $3,451.51 | 2024-2025 | Phasix Mesh, Channel Drain, Arista |
| Tela Bio, INC. | $3,401.47 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| W. L. Gore & Associates, INC. | $2,032.37 | 2023-2025 | Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Tas Medical, INC. | $1,522.30 | 2024 | |
| Kerecis Limited | $669.33 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medtronic, INC. | $559.36 | 2023-2025 | Sonicision, Signia, Emprint |
| Becton, Dickinson and Company | $479.21 | 2023-2024 | Phasix Mesh |
| Heron Therapeutics, INC. | $189.92 | 2022-2025 | Aponvie, Zynrelef |
| Sanara Medtech INC. | $150.73 | 2024 | Celleraterx |
| Ethicon US, LLC | $139.12 | 2023-2025 | Echelon Flex, Certus 140 |
| Boston Scientific Corporation | $128.18 | 2024-2025 | Spyglass Discover, General - Pain Management |
| Conmed Corporation | $123.49 | 2024 | Airseal |
| Aroa Biosurgery Incorporated | $48.16 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $36.02 | 2024-2025 | Exparel |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $35.20 | 2024 | Localizer |
| Innovation Technologies INC | $28.28 | 2024 | Irrisept |
| Histosonics, INC. | $25.93 | 2025 | |
| Dilon Technologies, INC. | $25.93 | 2024 | Hemoblast Bellows |
| Solventum Corporation | $25.71 | 2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo |
| Acera Surgical, INC. | $23.19 | 2024 | Restrata Wound Matrix |
| Eagle Pharmaceuticals, INC. | $19.91 | 2023 | |
| Merck Sharp & Dohme LLC | $18.58 | 2019 | |
| Genzyme Corporation | $13.74 | 2019 | |
| Karl Storz Endoscopy-America | $13.44 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Cobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.